Timothy A. Worrall Ph.D.

Partner

Denver
T +1.303.861.0600
F +1.303.861.7805
San Francisco
T +1.415.659.2655
F +1.415.659.2601

Overview

As a seasoned patent strategist, Tim Worrall has extensive experience working with clients in numerous industries, from the biotechnology and pharmaceuticals space to the material science, med-tech and computer architecture sectors, on their domestic and international patent portfolios. He develops patent portfolios that can be leveraged defensively to protect a client’s existing innovation, and offensively to protect intellectual property in a broader commercial space, all while aligning patent portfolios with the client's goals and objectives. Tim also provides strategic counsel on strengths and the potential weaknesses of a patent portfolio with a focus on approaches to increase the portfolio's value.

In the biotechnology sector, Tim has extensive experience developing patent portfolios to protect biotechnology patent portfolios, as well as develop strategies for biosimilar products. In the pharmaceutical sector, Tim has developed patent portfolios designed to withstand Hatch-Waxman litigation, and has separate experience in developing strategies for generic pharmaceuticals. In the material science and med-tech sectors, he develops patent strategies focused on commercial development. In the computer architecture sector, he has developed patent portfolios that can be monetized in a patent pool or leveraged against competitors.

As a former patent examiner at the U.S. Patent and Trademark Office, Tim possesses a thorough understanding of regulatory compliance statutes and procedures necessary for securing a strong patent in a variety of commercial contexts. Tim shares in his clients' goals of creating strong and extensive patent portfolios that protect their assets, and responds by aiding them in developing portfolios that can withstand their continually evolving and complex markets.

Select Experience

  • Developed multiple patent portfolios, including one drug from inception to pharmaceutical launch, over a 15-year period for a biopharmaceutical company. The intellectual property estate contributed to the acquisition of the company for nearly $500,000,000.
  • Developed patent portfolios from conception to product launch of a licensed biologic drug; developed and prosecuted the patent strategy for a licensed biologic compound.
  • Developed multiple material science patent portfolios.
More »

Experience

  • Developed multiple patent portfolios, including one drug from inception to pharmaceutical launch, over a 15-year period for a biopharmaceutical company. The intellectual property estate contributed to the acquisition of the company for nearly $500,000,000.
  • Developed patent portfolios from conception to product launch of a licensed biologic drug; developed and prosecuted the patent strategy for a licensed biologic compound.
  • Developed multiple material science patent portfolios.
  • Developed patent portfolios for multiple med-tech offerings, contributing to commercial strategies with strategic investors.
  • Prepared a patent portfolio that withstood multiple inter partes reviews, ultimately forcing settlement of patent litigation on asserted patents.

Recognitions and Memberships

Recognitions

  • Chambers USA: Intellectual Property in Colorado 
    • Band 3 (2015 to 2020)
  • Managing IP (Colorado) (2015 to 2018)
  • Lexology and International Law Office for Intellectual Property: Client Choice Award (2015)
  • IAM Patent 1000: The World's Leading Patent Practitioners
    • Colorado: Recommended for Patent Prosecution (2015 to 2021)
  • The Best Lawyers in America® (2021)
    • Colorado: Patent Law

Prior Positions

  • U.S. Patent and Trademark Office: Patent Examiner

Admissions

  • U.S. Patent and Trademark Office, Registration No. 54,552
  • Colorado
  • California

Education

  • J.D., Certificate in Intellectual Property, University of California, Berkeley School of Law, 2002; Berkeley Technology Law Journal, Development Editor
  • Ph.D., Biophysics and Biophysical Chemistry, Johns Hopkins University School of Medicine, 1999
  • B.S., Chemistry, concentration in Physics, The University of the South, 1993, cum laude; Phi Beta Kappa